PL363518A1 - Sposób wykrywania związków nadających się do leczenia i/lub profilaktyki otyłości - Google Patents

Sposób wykrywania związków nadających się do leczenia i/lub profilaktyki otyłości

Info

Publication number
PL363518A1
PL363518A1 PL01363518A PL36351801A PL363518A1 PL 363518 A1 PL363518 A1 PL 363518A1 PL 01363518 A PL01363518 A PL 01363518A PL 36351801 A PL36351801 A PL 36351801A PL 363518 A1 PL363518 A1 PL 363518A1
Authority
PL
Poland
Prior art keywords
prophylaxis
obesity
treatment
locating
compounds
Prior art date
Application number
PL01363518A
Other languages
English (en)
Other versions
PL201165B1 (pl
Inventor
Johannes Hebebrand
Jochen Antel
Ulf Preuschoff
Samuel David
Holger Sann
Michael Weske
Original Assignee
Solvay Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Gmbh filed Critical Solvay Pharmaceuticals Gmbh
Publication of PL363518A1 publication Critical patent/PL363518A1/pl
Publication of PL201165B1 publication Critical patent/PL201165B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL363518A 2000-07-20 2001-07-12 Sposób wykrywania związków nadających się do leczenia i/lub profilaktyki otyłości oraz zastosowanie tych związków PL201165B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035227A DE10035227A1 (de) 2000-07-20 2000-07-20 Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind
PCT/EP2001/008051 WO2002007821A1 (de) 2000-07-20 2001-07-12 Verfahren zum auffinden von verbindungen, welche zur behandlung und/oder prophylaxe von obesitas geeignet sind

Publications (2)

Publication Number Publication Date
PL363518A1 true PL363518A1 (pl) 2004-11-29
PL201165B1 PL201165B1 (pl) 2009-03-31

Family

ID=7649538

Family Applications (1)

Application Number Title Priority Date Filing Date
PL363518A PL201165B1 (pl) 2000-07-20 2001-07-12 Sposób wykrywania związków nadających się do leczenia i/lub profilaktyki otyłości oraz zastosowanie tych związków

Country Status (26)

Country Link
EP (1) EP1307262B1 (pl)
JP (1) JP2004504053A (pl)
KR (1) KR100818827B1 (pl)
CN (1) CN1443085B (pl)
AR (1) AR028730A1 (pl)
AT (1) ATE278441T1 (pl)
AU (2) AU7753401A (pl)
BR (1) BR0112547A (pl)
CA (1) CA2416647A1 (pl)
CZ (1) CZ2003156A3 (pl)
DE (2) DE10035227A1 (pl)
DZ (1) DZ3393A1 (pl)
ES (1) ES2230346T3 (pl)
HU (1) HUP0302309A3 (pl)
IL (2) IL153971A0 (pl)
MX (1) MXPA02012907A (pl)
NO (1) NO20030233L (pl)
NZ (1) NZ523960A (pl)
PL (1) PL201165B1 (pl)
PT (1) PT1307262E (pl)
RU (1) RU2268721C2 (pl)
SK (1) SK287607B6 (pl)
TR (1) TR200402670T4 (pl)
TW (1) TWI274157B (pl)
UA (1) UA74588C2 (pl)
WO (1) WO2002007821A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1997370B (zh) 2004-05-19 2011-06-01 索尔瓦药物有限公司 N-氨磺酰-n＇-芳基哌嗪类化合物在制备用于预防或治疗肥胖和相关疾病的药物中的用途
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
KR20080012360A (ko) 2005-05-20 2008-02-11 얀센 파마슈티카 엔.브이. 설파미드 유도체의 제조 방법
AR057570A1 (es) 2005-11-14 2007-12-05 Solvay Pharm Gmbh Derivados de n-sulfamoil-n'-benzopiranopiperidinas espirocondensadas, composiciones farmaceuticas que los comprenden, un procedimiento para su preparacion y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por las isoenzimas anhidrasas carbonicas subtipos ii y/o
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8492431B2 (en) 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
EA200870556A1 (ru) 2006-05-19 2009-06-30 Янссен Фармацевтика Н.В. Комбинированная терапия в лечении эпилепсии и родственных расстройств
JP5301465B2 (ja) 2007-01-25 2013-09-25 バーバ・ファーマシューティカルズ・リミテッド インスリン抵抗性改善薬および治療方法
EA018567B1 (ru) 2008-06-23 2013-08-30 Янссен Фармацевтика Нв Кристаллическая форма (2s)-(-)-n-(6-хлор-2,3-дигидробензо[1,4]диоксин-2-илметил)сульфамида
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US20150150855A1 (en) * 2012-05-24 2015-06-04 Verva Pharmaceuticals Ltd Method of improving liver function
CN106770611B (zh) * 2016-12-22 2019-01-29 广西师范大学 一种用于细胞原位检测小分子化合物进入线粒体的方法
RU2771430C1 (ru) * 2021-09-21 2022-05-04 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Способ количественного определения антиконвульсантов в плазме крови больных эпилепсией

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552897A (en) * 1983-02-01 1985-11-12 American Cyanamid Company Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
US4952567A (en) * 1988-05-09 1990-08-28 City Of Hope Inhibition of lipogenesis
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
ZA932660B (en) * 1992-04-17 1993-10-26 Sankyo Co Derivatives of adipogenesis inhibitory factor, their preparation and their use
TJ286B (en) * 1992-10-29 2000-12-13 Genentech Inc A method for treatment or prevention of obesity
AU693478B2 (en) * 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity
RU2214241C2 (ru) * 1996-06-28 2003-10-20 Орто-Макнейл Фармасьютикал, Инк. Способ лечения ожирения и способ индуцирования потери веса у млекопитающих
US5727570A (en) * 1996-11-14 1998-03-17 Clemens; Anton H. Method of treating hyperlipidemia in humans
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor

Also Published As

Publication number Publication date
PT1307262E (pt) 2004-12-31
AR028730A1 (es) 2003-05-21
NO20030233L (no) 2003-03-19
SK612003A3 (en) 2003-06-03
KR100818827B1 (ko) 2008-04-01
RU2268721C2 (ru) 2006-01-27
CZ2003156A3 (cs) 2003-06-18
EP1307262A1 (de) 2003-05-07
IL153971A0 (en) 2003-07-31
NZ523960A (en) 2004-12-24
WO2002007821A1 (de) 2002-01-31
PL201165B1 (pl) 2009-03-31
HK1057499A1 (zh) 2004-04-08
SK287607B6 (sk) 2011-03-04
DZ3393A1 (fr) 2002-01-31
BR0112547A (pt) 2003-07-01
AU7753401A (en) 2002-02-05
ATE278441T1 (de) 2004-10-15
ES2230346T3 (es) 2005-05-01
IL153971A (en) 2009-07-20
AU2001277534B2 (en) 2005-09-29
CN1443085A (zh) 2003-09-17
HUP0302309A2 (hu) 2003-11-28
NO20030233D0 (no) 2003-01-17
MXPA02012907A (es) 2003-09-22
JP2004504053A (ja) 2004-02-12
TWI274157B (en) 2007-02-21
DE10035227A1 (de) 2002-01-31
HUP0302309A3 (en) 2005-06-28
KR20030022284A (ko) 2003-03-15
TR200402670T4 (tr) 2004-11-22
DE50104023D1 (de) 2004-11-11
AU2001277534B9 (en) 2006-02-23
CN1443085B (zh) 2010-04-28
UA74588C2 (en) 2006-01-16
CA2416647A1 (en) 2003-01-20
EP1307262B1 (de) 2004-10-06

Similar Documents

Publication Publication Date Title
PL364995A1 (pl) Sposób leczenia lub zapobiegania infekcjom wywołanym przez Flavivirus przy użyciu analogów nukleozydów
AU8870701A (en) Materials and methods for the treatment or prevention of obesity
PL369237A1 (pl) Mikroorganizmy do traktowania gleby i sposób ich otrzymywania
EP1343726A4 (en) METHODS AND COMPOSITIONS FOR WATER TREATMENT
HUP0302739A3 (en) Method for the treatment of tobacco
EP1337255A4 (en) USE OF P38 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY COUGH
AU7753401A (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
AU2001277534A1 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
AU2003263760A1 (en) Methods for the treatment or prevention of obesity
AU2002364171A8 (en) Materials and methods for the treatment or prevention of obesity
AU7750100A (en) Method for the treatment of obesity
IL155769A0 (en) Method for the treatment of inflammation
PL366404A1 (pl) Sposób traktowania
IL144718A0 (en) Method and apparatus for the treatment of domestic waste
AU6137801A (en) Method and composition for the treatment of angiogenesis
GB0008921D0 (en) Method of treatment
GB0118892D0 (en) Method of treatment
AU2002365621A8 (en) Composition for treating the surface of the skin
SI1307262T1 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
EP1450849A4 (en) METHOD FOR TREATING ENDOMETREOSE
GB0027001D0 (en) Method and apparatus for the treatment of sludge
GB0106711D0 (en) Method and apparatus for treatment of conduits and the like
GB0001861D0 (en) Method for the treatment of obesity
AU2000272704A1 (en) Use of compounds for the treatment of obesity
GB9924275D0 (en) Method for the treatment of obesity

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20120712